These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
328 related items for PubMed ID: 14534532
21. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers. Hilgers W, Song JJ, Haye M, Hruban RR, Kern SE, Fearon ER. Genes Chromosomes Cancer; 2000 Apr; 27(4):353-7. PubMed ID: 10719364 [Abstract] [Full Text] [Related]
22. Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas. Goggins M, Shekher M, Turnacioglu K, Yeo CJ, Hruban RH, Kern SE. Cancer Res; 1998 Dec 01; 58(23):5329-32. PubMed ID: 9850059 [Abstract] [Full Text] [Related]
23. [The effects of transferring DPC4-adenovirus on pancreatic adenocarcinoma cells]. Feng XL, Zhang ZD, Tian L, Wei YQ. Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep 01; 35(5):607-11. PubMed ID: 15460398 [Abstract] [Full Text] [Related]
24. Overexpression of the tumor suppressor gene Smad4/DPC4 induces p21waf1 expression and growth inhibition in human carcinoma cells. Hunt KK, Fleming JB, Abramian A, Zhang L, Evans DB, Chiao PJ. Cancer Res; 1998 Dec 15; 58(24):5656-61. PubMed ID: 9865717 [Abstract] [Full Text] [Related]
25. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination. Tarafa G, Villanueva A, Farré L, Rodríguez J, Musulén E, Reyes G, Seminago R, Olmedo E, Paules AB, Peinado MA, Bachs O, Capellá G. Oncogene; 2000 Jan 27; 19(4):546-55. PubMed ID: 10698524 [Abstract] [Full Text] [Related]
26. Smad4 induces the tumor suppressor E-cadherin and P-cadherin in colon carcinoma cells. Müller N, Reinacher-Schick A, Baldus S, van Hengel J, Berx G, Baar A, van Roy F, Schmiegel W, Schwarte-Waldhoff I. Oncogene; 2002 Sep 05; 21(39):6049-58. PubMed ID: 12203117 [Abstract] [Full Text] [Related]
27. Dual role of Ski in pancreatic cancer cells: tumor-promoting versus metastasis-suppressive function. Wang P, Chen Z, Meng ZQ, Fan J, Luo JM, Liang W, Lin JH, Zhou ZH, Chen H, Wang K, Shen YH, Xu ZD, Liu LM. Carcinogenesis; 2009 Sep 05; 30(9):1497-506. PubMed ID: 19546161 [Abstract] [Full Text] [Related]
29. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function. Schniewind B, Groth S, Sebens Müerköster S, Sipos B, Schäfer H, Kalthoff H, Fändrich F, Ungefroren H. Oncogene; 2007 Jul 19; 26(33):4850-62. PubMed ID: 17297450 [Abstract] [Full Text] [Related]
30. Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus. Natsugoe S, Xiangming C, Matsumoto M, Okumura H, Nakashima S, Sakita H, Ishigami S, Baba M, Takao S, Aikou T. Clin Cancer Res; 2002 Jun 19; 8(6):1838-42. PubMed ID: 12060625 [Abstract] [Full Text] [Related]
31. Functional blockade of Smad4 leads to a decrease in beta-catenin levels and signaling activity in human pancreatic carcinoma cells. Romero D, Iglesias M, Vary CP, Quintanilla M. Carcinogenesis; 2008 May 19; 29(5):1070-6. PubMed ID: 18310088 [Abstract] [Full Text] [Related]
32. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells. Azuma H, Ehata S, Miyazaki H, Watabe T, Maruyama O, Imamura T, Sakamoto T, Kiyama S, Kiyama Y, Ubai T, Inamoto T, Takahara S, Itoh Y, Otsuki Y, Katsuoka Y, Miyazono K, Horie S. J Natl Cancer Inst; 2005 Dec 07; 97(23):1734-46. PubMed ID: 16333029 [Abstract] [Full Text] [Related]
33. STAT1 and Nmi are downstream targets of Ets-1 transcription factor in MCF-7 human breast cancer cell. Jung HH, Lee J, Kim JH, Ryu KJ, Kang SA, Park C, Sung K, Nam DH, Kang WK, Park K, Im YH. FEBS Lett; 2005 Jul 18; 579(18):3941-6. PubMed ID: 15996661 [Abstract] [Full Text] [Related]
34. Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. Schwarte-Waldhoff I, Volpert OV, Bouck NP, Sipos B, Hahn SA, Klein-Scory S, Lüttges J, Klöppel G, Graeven U, Eilert-Micus C, Hintelmann A, Schmiegel W. Proc Natl Acad Sci U S A; 2000 Aug 15; 97(17):9624-9. PubMed ID: 10944227 [Abstract] [Full Text] [Related]
35. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4. Kretschmer A, Moepert K, Dames S, Sternberger M, Kaufmann J, Klippel A. Oncogene; 2003 Oct 02; 22(43):6748-63. PubMed ID: 14555988 [Abstract] [Full Text] [Related]
36. Over-expression of TGF-beta1 in Smad4-deficient human oral carcinoma cells causes tumour regression in vivo by mechanisms that sensitize cells to apoptosis. Thavaraj S, Paterson IC, Hague A, Prime SS. J Pathol; 2005 Jan 02; 205(1):14-20. PubMed ID: 15546158 [Abstract] [Full Text] [Related]
37. Transfer of chromosome 18 into human head and neck squamous carcinoma cells: evidence for tumor suppression by Smad4/DPC4. Reiss M, Santoro V, de Jonge RR, Vellucci VF. Cell Growth Differ; 1997 Apr 02; 8(4):407-15. PubMed ID: 9101086 [Abstract] [Full Text] [Related]
38. Expression of the ets-1 proto-oncogene in human pancreatic carcinoma. Ito T, Nakayama T, Ito M, Naito S, Kanematsu T, Sekine I. Mod Pathol; 1998 Feb 02; 11(2):209-15. PubMed ID: 9504693 [Abstract] [Full Text] [Related]